REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Shine-On BioMedical Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shine-On BioMedical Co., Ltd. Profile Updated: June 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shine-On BioMedical Co., Ltd. is engaged in the development of multi-specific antibody drugs and nucleic acid therapeutic drugs. The company's main products include antibody anti-cancer drugs and nucleic acid anti-cancer drugs. The company was established in 2021 and is headquartered in Taichung City, Taiwan.

Headquarters
Unit 6, 5F, 633 Taiwan Blvd, Sec. 2 Xitun Dist
Taichung City; Taichung City;

Contact Details: Purchase the Shine-On BioMedical Co., Ltd. report to view the information.

Website: http://www.shineon-bio.com

Basic Information
Total Employees:
Purchase the Shine-On BioMedical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Shine-On BioMedical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Shine-On BioMedical Co., Ltd. report to view the information.
Incorporation Date:
April 06, 2021
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
11.4%
Purchase this report to view the information.
5.73%
Purchase this report to view the information.
1.72%
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Shine-On BioMedical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-105.34%▼
EBITDA
-402.31%▼
Net Profit (Loss) for the Period
-263.2%▼
Total assets
-4.54%▼
Total equity
-6.1%▼
Return on Equity (ROE)
-3.16%▼
Quick Ratio
-251.56%▼
Cash Ratio
-94.04%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo